Theratechnologies (TSE:TH) Releases Earnings Results

Theratechnologies (TSE:TH) posted its quarterly earnings results on Thursday. The company reported C$0.09 EPS for the quarter, reports. Theratechnologies had a negative return on equity of 1,116.86% and a negative net margin of 8.47%. The business had revenue of C$30.96 million during the quarter.

Theratechnologies Stock Down 0.6 %

Shares of TH opened at C$1.74 on Friday. The firm’s 50-day simple moving average is C$1.74 and its 200 day simple moving average is C$1.83. The company has a debt-to-equity ratio of 562.07, a quick ratio of 0.64 and a current ratio of 1.10. The firm has a market cap of C$80.01 million, a P/E ratio of -9.67, a price-to-earnings-growth ratio of -8.50 and a beta of 1.73. Theratechnologies has a 52 week low of C$1.27 and a 52 week high of C$3.43.

Theratechnologies Company Profile

Theratechnologies Inc, a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen.